Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 5401–5450 of 18644
On May 12, 2024, the Board appointed Ronald T. Nixon, the Company’s Executive Chairman, as the Chief Executive Officer of the Company, effective immediately.
On May 10, 2024 (the “Effective Date”), Zachary B. Fleming delivered notice to the Board of Directors of the Company (the “Board”) that he is resigning from his position as Chief Executive Officer of the Company, effective immediately.
On May 11, 2024, the board of directors (the “Board”) of Marathon Petroleum Corporation (the “Company”) appointed Maryann T. Mannen as Chief Executive Officer of the Company, effective August 1, 2024.
appointed Maryann T. Mannen as President and Chief Executive Officer, effective August 1, 2024.
On May 10, 2024, Equity Bancshares, Inc. (the “Company”) announced the promotion of Richard M. Sems to Chief Executive Officer of Equity Bank.
announced that Joseph Ciaffoni will step down as the President and Chief Executive Officer of Collegium Pharmaceutical, Inc. (the “Company”) effective May 24, 2024.
the Board approved the appointment of Michael Heffernan, the Company’s Chairman of the Board, to Interim President and Chief Executive Officer, effective May 24, 2024
On May 8, 2024, the Board of the Company appointed Rajneesh Vig to the Board of Directors the Company as Chair and appointed him as Chief Executive Officer (“CEO”) of the Company, with the appointments effective immediately.
On April 1, 2024, the Company issued a press release announcing Claudia Jaramillo’s departure from the Company and Kevin Berryman’s appointment as the Company’s interim Chief Financial Officer.
On April 1, 2024, the Company issued a press release announcing Claudia Jaramillo’s departure from the Company and Kevin Berryman’s appointment as the Company’s interim Chief Financial Officer.
On May 10, 2024, Mr. Anthony Geisler, Chief Executive Officer and Director of Xponential Fitness, Inc. (the “Company”), was removed by the Company’s Board of Directors from his duties and suspended indefinitely as Chief Executive Officer.
The Company’s Board of Directors has appointed Ms. Brenda Morris, a member of the Company’s Board of Directors since 2019, to serve as the Company’s Interim Chief Executive Officer.
Ms. Shirley Cheng, the Chief Financial Officer, Corporate Secretary and Director of Network CN Inc. (the “Company”) notified the Company of her intention to resign from her position for personal reasons. Ms. Cheng’s resignation will become effective on May 12, 2024.
the Board appointed Adam K. Peterson as the sole Chairman and sole Chief Executive Officer of the Company, succeeding Mr. Rozek
On May 6, 2024, A. Allen Arroyo, Chief Financial Officer, principal financial officer and principal accounting officer of Rocky Mountain Chocolate Factory, Inc. (the “Company”), notified the Company of his intention to resign effective May 17, 2024.
the Board appointed Mr. Liu as President/CEO
Mr. Wang as CFO
On May 10, 2024, Brixmor Property Group Inc. (the “Company”) announced that James M. Taylor Jr., the Company’s Chief Executive Officer and President, will return from his medical leave of absence and reassume his duties as the Company’s Chief Executive Officer and President, effective May 20, 2024.
On the Effective Date, the Company appointed Mark Boelke as Chief Financial Officer and Treasurer of the Company, effective immediately.
On May 9, 2024 (the "Effective Date"), Entravision Communications Corporation (the “Company”) terminated the employment of Christopher T. Young, Chief Financial Officer, and Juan Saldívar von Wuthenau, Chief Strategy and Business Development Officer, each effective immediately.
On May 9, 2024, Quaker Chemical Corporation (the “Company”) announced the termination of the employment of Shane Hostetter, as the Company’s Chief Financial Officer, effective as of June 7, 2024.
On May 6, 2024, the Board of Directors of the Company appointed Tom Coler, age 50, to Executive Vice President and Chief Financial Officer, effective June 10, 2024.
Effective May 9, 2024, Mina Kim was appointed as the Chief Executive Officer of the Company and was appointed as a member of the Board of Directors of the Company (the “Board”).
By mutual agreement of Shao-Lee Lin, M.D., Ph.D. and the Company, Dr. Lin stepped down from her position as Chief Executive Officer and as a member of the Board, effective on May 8, 2024.
On May 7, 2024, Dr. James N. Woody resigned as Chief Executive Officer (Principal Executive Officer), and as a member of the Board of Directors, of 180 Life Sciences Corp. (the “ Company ”, “ we ” and “ us ”) effective the same date
On May 3, 2024, Wesley Sima resigned as Chief Financial Officer of RMG Acquisition Corp. III (the “Company”).
On May 3, 2024, Brian Zasitko, Chief Financial Officer of the Company, resigned, effective May 17, 2024.
the Board appointed Ryan Confer, Chief Financial Officer of Genprex since 2016, to serve as President and Chief Executive Officer of Genprex (in addition to his position as Chief Financial Officer of Genprex), effective immediately
Rodney Varner, the Company’s President and Chief Executive Officer and Chairman of the Company’s Board of Directors (the “Board”), passed away unexpectedly on May 7, 2024 due to complications from an ongoing illness.
Dr. Stephen Schwartz informed the Company of his intention to retire from his position as President and Chief Executive Officer and a director of the Company
On May 9, 2024, in connection with Mr. Fosty’s appointment as the Company’s Interim Chief Financial Officer, the Company entered into an Employment Offer Letter with Mr. Fosty
Dr. Coffman succeeds Sherif Abdou, M.D., who resigned from his positions as Chief Executive Officer and President of the Company effective as of the Effective Time.
appointed Aric Coffman, M.D. as Chief Executive Officer and President of the Company, effective at 12:00 p.m. Eastern Time on May 8, 2024
On May 8, 2024, following a search process, the Board of Directors (the “Board”) of the Company appointed Cynthia Williams as the Company’s Chief Executive Officer and a Class II director, in each case effective May 20, 2024 (the “Effective Date”).
Ms. Williams succeeds Michael Lunsford, the Company’s Interim Chief Executive Officer.
Mr. Maher will replace Jay Stasz, the Company’s current Chief Financial Officer and Treasurer.
On May 06, 2024, the Board of Directors (the “Board”) of the Company appointed Michael Maher as the Company’s Chief Financial Officer and Treasurer, effective May 13, 2024.
appointed Tarang Sharma to serve as Interim Chief Financial Officer, effective May 27, 2024
notified the Company of his decision to resign from his position with the Company, effective May 29, 2024
Michael D. Stornant notified Wolverine World Wide, Inc. (the “Company”) of his intention to retire, and, effective May 8, 2024 (the “Transition Date”), Mr. Stornant will step down as Chief Financial Officer of the Company but will remain employed for a period of time to assist with the smooth transition of his duties.
The Company’s Board of Directors (the “Board”) has appointed Taryn Miller to serve as the Company’s new Chief Financial Officer, effective May 9, 2024.
Effective on May 7, 2024, Jeffrey Rittichier departed as Chief Executive Officer, Principal Executive Officer and director of the Company.
Effective on May 8, 2024, the Company appointed Matthew Vargas, the Company’s current VP, Sales, as interim Chief Executive Officer.
Walter F. Rusnak, Senior Vice President and Chief Financial Officer of the Company and Pathfinder Bank (the “Bank”) notified the Company and the Bank of his decision to retire from his positions effective June 28, 2024.
Justin K. Bigham, age 50, was named Senior Vice President and Chief Financial Officer of the Company and the Bank effective June 28, 2024.
Concurrently with Ms. Rooney’s transition, the Company announced that Jeremy J. Heaton has been appointed as its Chief Financial Officer.
Katie J. Rooney, who has served as Global Chief Financial Officer and Chief Operating Officer since August 2023 and as Chief Financial Officer of Alight since May 2017, is stepping down from the role of Global Chief Financial Officer as of the end of the day on May 8, 2024 (the “Effective Date”).
Kevin Lawrence, who has served as the Company’s Chief Financial Officer since April 1, 2015, resigned from his position with the Company effective May 7, 2024, to pursue other career interests.
the Board of Directors of the Company appointed Ms. Hannah Andrus Executive Vice President, Chief Financial Officer and Treasurer, to be effective May 8, 2024.
selected Robert A. Michael to succeed Richard A. Gonzalez as AbbVie’s Chief Executive Officer (CEO), effective July 1, 2024
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.